Prescription Psychedelics: The Road from FDA Approval to Clinical Practice
Am J Med
.
2022 Jan;135(1):15-16.
doi: 10.1016/j.amjmed.2021.07.033.
Epub 2021 Aug 21.
Author
Matt Lamkin
1
Affiliation
1
Associate Professor, University of Tulsa College of Law, Tulsa, Okla. Electronic address: matt-lamkin@utulsa.edu.
PMID:
34428464
DOI:
10.1016/j.amjmed.2021.07.033
No abstract available
Publication types
Editorial
MeSH terms
Clinical Trials as Topic
Drug Prescriptions*
Drug and Narcotic Control*
Hallucinogens / therapeutic use*
Humans
Substances
Hallucinogens